Scholarlink

Background and Aim <p>Melanocytic nevi are common benign melanocytic proliferations, whereas malignant melanoma is an aggressive tumor with increasing incidence worldwide. Suprabasin (SBSN), isthmin-1 (ISM-1), and podocalyxin (PODXL) have been implicated in tumor development and progression. This study aimed to evaluate and compare the immunohistochemical expression of SBSN, ISM-1, and PODXL in malignant melanoma, melanocytic nevus, and normal skin.</p> Materials and Methods <p>The study included 20 malignant melanoma, 20 melanocytic nevus, and 20 normal skin samples archived at the Department of Pathology. Immunohistochemical staining was performed using antibodies against SBSN, ISM-1, and PODXL. Histoscores were calculated based on staining intensity and distribution. Statistical analyses were conducted using SPSS v22.0, and <i>p</i> &lt; 0.05 was considered significant.</p> Results <p>SBSN and ISM-1 expression levels were significantly lower in malignant melanoma compared to both control and melanocytic nevus groups (<i>p</i> &lt; 0.05), whereas both markers showed significantly increased expression in the melanocytic nevus group. PODXL expression was significantly higher in the malignant melanoma and melanocytic nevus groups compared to controls (<i>p</i> &lt; 0.001). No statistically significant difference in PODXL expression was observed between the malignant melanoma and melanocytic nevus groups (<i>p</i> = 0.780).</p> Conclusion <p>Decreased SBSN and ISM-1 expression and increased PODXL expression may be associated with melanocytic lesion biology. However, since PODXL expression did not differ significantly between nevi and melanoma, its role in malignant transformation remains unclear.. These findings suggest that SBSN, ISM-1, and PODXL may play potential roles in the pathogenesis of melanocytic lesions and could provide useful insights for future studies investigating molecular mechanisms of melanoma progression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunohistochemical Evaluation of Suprabasin, Isthmin-1, and Podocalyxin Immunoreactivity in Malignant Melanoma and Melanocytic Nevus

  • 期刊论文

  • 发表日期：

    2026年4月4日

查看全文
  • Nagehan Cepik,
  • Betül Demir,
  • Demet Cicek,
  • Tuncay Kuloğlu,
  • Özlem Ucer,
  • Mehmet Semih Celik,
  • Kısmet Kaya,
  • Mahir Dıgıs,
  • Serhat Hancer

摘要

Background and Aim

Melanocytic nevi are common benign melanocytic proliferations, whereas malignant melanoma is an aggressive tumor with increasing incidence worldwide. Suprabasin (SBSN), isthmin-1 (ISM-1), and podocalyxin (PODXL) have been implicated in tumor development and progression. This study aimed to evaluate and compare the immunohistochemical expression of SBSN, ISM-1, and PODXL in malignant melanoma, melanocytic nevus, and normal skin.

Materials and Methods

The study included 20 malignant melanoma, 20 melanocytic nevus, and 20 normal skin samples archived at the Department of Pathology. Immunohistochemical staining was performed using antibodies against SBSN, ISM-1, and PODXL. Histoscores were calculated based on staining intensity and distribution. Statistical analyses were conducted using SPSS v22.0, and p < 0.05 was considered significant.

Results

SBSN and ISM-1 expression levels were significantly lower in malignant melanoma compared to both control and melanocytic nevus groups (p < 0.05), whereas both markers showed significantly increased expression in the melanocytic nevus group. PODXL expression was significantly higher in the malignant melanoma and melanocytic nevus groups compared to controls (p < 0.001). No statistically significant difference in PODXL expression was observed between the malignant melanoma and melanocytic nevus groups (p = 0.780).

Conclusion

Decreased SBSN and ISM-1 expression and increased PODXL expression may be associated with melanocytic lesion biology. However, since PODXL expression did not differ significantly between nevi and melanoma, its role in malignant transformation remains unclear.. These findings suggest that SBSN, ISM-1, and PODXL may play potential roles in the pathogenesis of melanocytic lesions and could provide useful insights for future studies investigating molecular mechanisms of melanoma progression.